{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:44:29Z","timestamp":1787798669175,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","americanjournalofsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.amjsurg.2024.116005","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T22:08:21Z","timestamp":1728166101000},"page":"116005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The association of genetic testing timing and mutation type on breast cancer management in patients with breast cancer-related mutations"],"prefix":"10.1016","volume":"239","author":[{"given":"Ebunoluwa J.","family":"Olunuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koumani W.","family":"Ntowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet C.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-0558","authenticated-orcid":false,"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2024.116005_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.amjsurg.2024.116005_bib2","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1002\/jcp.27464","article-title":"Hereditary breast cancer; Genetic penetrance and current status with BRCA","volume":"234","author":"Mahdavi","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.amjsurg.2024.116005_bib3","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.amjsurg.2024.116005_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.amjsurg.2024.116005_bib5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2741\/4185","article-title":"Breast cancer genes: beyond BRCA1 and BRCA2","volume":"18","author":"Filippini","year":"2013","journal-title":"Front Biosci"},{"key":"10.1016\/j.amjsurg.2024.116005_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes - association analysis in more than 113,000 women","volume":"384","author":"Dorling","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjsurg.2024.116005_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.breast.2022.06.003","article-title":"Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D","volume":"65","author":"Graffeo","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.amjsurg.2024.116005_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.gde.2010.02.009","article-title":"Discovering moderate-risk breast cancer susceptibility genes","volume":"20","author":"Hollestelle","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.amjsurg.2024.116005_bib9","series-title":"Breast Cancer Risk Reduction (Version 2.2024)","author":"Network","year":"2024"},{"key":"10.1016\/j.amjsurg.2024.116005_bib10","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.02225","article-title":"Germline testing in patients with breast cancer: ASCO-society of surgical Oncology guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2024.116005_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024 featured updates to the NCCN guidelines","volume":"21","author":"Daly","year":"2023","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.amjsurg.2024.116005_bib12","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","article-title":"Consensus guidelines on genetic testing for hereditary breast cancer from the American society of breast Surgeons","volume":"26","author":"Manahan","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2024.116005_bib13","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1245\/s10434-016-5328-7","article-title":"Impact that timing of genetic mutation diagnosis has on surgical decision making and outcome for BRCA1\/BRCA2 mutation carriers with breast cancer","volume":"23","author":"Chiba","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2024.116005_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.18486","article-title":"Clinical outcomes for BRCA pathogenic variant carriers with breast cancer undergoing breast conservation","volume":"7","author":"Wanis","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjsurg.2024.116005_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/jamasurg.2022.2065","article-title":"Analysis of a trend reversal in US lumpectomy rates from 2005 through 2017 using 3 nationwide data sets","volume":"157","author":"Nelson","year":"2022","journal-title":"Jama Surg"},{"key":"10.1016\/j.amjsurg.2024.116005_bib16","doi-asserted-by":"crossref","first-page":"E226","DOI":"10.1200\/OP.20.00571","article-title":"Utilization, timing, and outcomes of BRCA genetic testing among women with newly diagnosed breast cancer from a national commercially insured population: the ABOARD study","volume":"17","author":"Armstrong","year":"2021","journal-title":"Jco Oncol Pract"},{"key":"10.1016\/j.amjsurg.2024.116005_bib17","article-title":"Timing of genetic testing in BRCA1\/2 and PALB2-Associated breast cancer: preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy","volume":"50","author":"Apostolova","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.amjsurg.2024.116005_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.soc.2021.08.004","article-title":"Disparities in genetic testing for heritable solid-tumor malignancies","volume":"31","author":"Dillon","year":"2022","journal-title":"Surg Oncol Clin"},{"key":"10.1016\/j.amjsurg.2024.116005_bib19","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1200\/JCO.21.01426","article-title":"Genetic counseling and testing in African American patients with breast cancer: a Nationwide survey of us breast oncologists","volume":"39","author":"Ademuyiwa","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2024.116005_bib20","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.2017.76.2369","article-title":"Gaps in receipt of clinically indicated genetic counseling after diagnosis of breast cancer","volume":"36","author":"Katz","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2024.116005_bib21","first-page":"340","article-title":"Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancers","volume":"32","author":"Swink","year":"2019","journal-title":"SAVE Proc"},{"key":"10.1016\/j.amjsurg.2024.116005_bib22","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS22-P6-02-02","article-title":"Challenges and dilemmas following a traceback approach for genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer","volume":"83","author":"Tamimi","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjsurg.2024.116005_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10549-021-06351-z","article-title":"Genetic testing in women with early-onset breast cancer: a Traceback pilot study","volume":"190","author":"Augustinsson","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.amjsurg.2024.116005_bib24","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1200\/JCO.2016.70.3439","article-title":"Traceback: a proposed framework to increase identification and genetic counseling of BRCA1 and BRCA2 mutation carriers through family-based outreach","volume":"35","author":"Samimi","year":"2017","journal-title":"J\u00a0Clin Oncol"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961024005579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961024005579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T15:11:27Z","timestamp":1734102687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961024005579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"alternative-id":["S0002961024005579"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2024.116005","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of genetic testing timing and mutation type on breast cancer management in patients with breast cancer-related mutations","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2024.116005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116005"}}